- Home
- WOOF vs EMBC Comparison
WOOF vs EMBC Comparison
Compare WOOF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- EMBC
- Stock Information
- Founded
- WOOF 1965
- EMBC 1924
- Country
- WOOF United States
- EMBC United States
- Employees
- WOOF N/A
- EMBC N/A
- Industry
- WOOF Other Specialty Stores
- EMBC Medical/Dental Instruments
- Sector
- WOOF Consumer Discretionary
- EMBC Health Care
- Exchange
- WOOF Nasdaq
- EMBC Nasdaq
- Market Cap
- WOOF 937.4M
- EMBC 788.4M
- IPO Year
- WOOF 2021
- EMBC N/A
- Fundamental
- Price
- WOOF $3.60
- EMBC $15.09
- Analyst Decision
- WOOF Hold
- EMBC Buy
- Analyst Count
- WOOF 11
- EMBC 2
- Target Price
- WOOF $3.91
- EMBC $18.50
- AVG Volume (30 Days)
- WOOF 4.6M
- EMBC 507.0K
- Earning Date
- WOOF 08-28-2025
- EMBC 08-08-2025
- Dividend Yield
- WOOF N/A
- EMBC 3.90%
- EPS Growth
- WOOF N/A
- EMBC 18.26
- EPS
- WOOF N/A
- EMBC 1.42
- Revenue
- WOOF $6,045,495,000.00
- EMBC $1,102,500,000.00
- Revenue This Year
- WOOF $0.03
- EMBC N/A
- Revenue Next Year
- WOOF $1.36
- EMBC N/A
- P/E Ratio
- WOOF N/A
- EMBC $10.82
- Revenue Growth
- WOOF N/A
- EMBC N/A
- 52 Week Low
- WOOF $2.28
- EMBC $9.20
- 52 Week High
- WOOF $6.29
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- WOOF 54.00
- EMBC 66.30
- Support Level
- WOOF $3.57
- EMBC $14.51
- Resistance Level
- WOOF $4.19
- EMBC $15.44
- Average True Range (ATR)
- WOOF 0.22
- EMBC 0.50
- MACD
- WOOF 0.01
- EMBC -0.04
- Stochastic Oscillator
- WOOF 47.22
- EMBC 80.53
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.